e-learning
resources
Vienna 2012
Monday, 03.09.2012
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Apolipoprotein A1 (ApoA1) abrogate cigarette smoke induced emphysema in mice
D. Kim, S. Park, J. J. Shim (Bucheon, Seoul, Republic Of Korea)
Source:
Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session:
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session type:
Thematic Poster Session
Number:
2122
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Kim, S. Park, J. J. Shim (Bucheon, Seoul, Republic Of Korea). LATE-BREAKING ABSTRACT: Apolipoprotein A1 (ApoA1) abrogate cigarette smoke induced emphysema in mice. Eur Respir J 2012; 40: Suppl. 56, 2122
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
LATE-BREAKING ABSTRACT: BRP-39 contribute to cigarette smoke-induced inflammation and emphysema in mice and humans
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Increased apolipoprotein E (ApoE) gene expression in an alveolar macrophage subpopulation of NO
2
-exposed rats
Source: Eur Respir J 2004; 24: Suppl. 48, 102s
Year: 2004
Staphylococcus aureus
enterotoxin B exacerbates cigarette smoke-induced pulmonary inflammation in mice
Source: Annual Congress 2010 - Pathology and immunology of COPD
Year: 2010
Apolipoprotein A-IV is reduced in serum of allergic patients and acts as an endogenous anti-inflammatory protein.
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
LATE-BREAKING ABSTRACT: Effect of vitamin D on inflammatory and antibacterial responses to cigarette smoke
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Elevated serum levels of oxidized low-density lipoprotein in COPD patients
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Role of ß2-adrenergic receptor in cigarette smoke-induced COPD in mice
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
LATE-BREAKING ABSTRACT: Aryl hydocarbon receptor and FosL1 are critical for cigarette smoke and TNF mediated activation of bronchial epithelial cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Attenuation of lung inflammation and emphysema induced by cigarette smoke exposure in CXCR3 knockout mice
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
A selective MMP-12 inhibitor, MV062926, reduces inflammatory responses to cigarette smoke in mice
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Liver growth factor (LGF) reverts experimental lung emphysema induced by tobacco smoke in mice
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
LATE-BREAKING ABSTRACT: The involvement of serotonin in cigarette smoke-induced airway remodeling in mice
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Roflumilast inhibited emphysema development in mice exposed to cigarette smoke
Source: Eur Respir J 2005; 26: Suppl. 49, 204s
Year: 2005
Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
LATE-BREAKING ABSTRACT: Time course effects of exercise training on pulmonary injury induced by exposure to cigarette smoke in mice
Source: Annual Congress 2013 –Passive smoking, children and students (young adults)
Year: 2013
LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL-C) and longitudinal lung function in six United States (US) cohorts
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept